Skip to main content
EPC
NYSE Industrial Applications And Services

Edgewell Reports Significant Q2 Net Loss Amid Restructuring and Divestiture Impacts

Analysis by Arik Shkolnikov
Sentiment info
Negative
Importance info
8
Price
$22.39
Mkt Cap
$1.046B
52W Low
$15.88
52W High
$30.525
Market data snapshot near publication time

summarizeSummary

Edgewell Personal Care reported a substantial net loss for Q2 and year-to-date fiscal 2026, driven by a goodwill impairment from its Feminine Care divestiture and declining gross margins in continuing operations, despite adjusted EPS exceeding analyst estimates.


check_boxKey Events

  • Significant Net Loss Reported

    The company reported a Q2 net loss of $10.6 million and a year-to-date net loss of $76.3 million, a substantial decline from the prior year's net income.

  • Goodwill Impairment Charge

    A $37.4 million goodwill impairment charge related to the divested Feminine Care segment significantly contributed to the year-to-date loss.

  • Feminine Care Divestiture Completed

    The sale of the Feminine Care segment closed on February 2, 2026, generating $340 million in proceeds which were used to reduce debt.

  • Declining Profitability

    Gross profit margin decreased by 410 basis points in Q2 to 41.8% and by 380 basis points year-to-date to 40.1%, indicating operational pressures.


auto_awesomeAnalysis

Edgewell Personal Care reported a substantial GAAP net loss for Q2 and year-to-date fiscal 2026, primarily driven by a $37.4 million goodwill impairment charge related to the recently divested Feminine Care segment. While adjusted diluted EPS for continuing operations of $0.60 for Q2 surpassed analyst expectations, it still represents a decline from the prior year. The company also experienced a notable decrease in gross profit margins, indicating underlying operational pressures. Edgewell is actively pursuing extensive restructuring initiatives, with $90 million in charges anticipated for fiscal 2026, aimed at improving efficiency. Positively, proceeds from the Feminine Care divestiture were used to significantly reduce long-term debt, and the company continues its share repurchase program. However, the overall GAAP losses, declining margins, and the context of lowered guidance (as per the related 8-K) suggest a challenging financial outlook.

At the time of this filing, EPC was trading at $22.39 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $1B. The 52-week trading range was $15.88 to $30.53. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed EPC - Latest Insights

EPC
May 06, 2026, 4:40 PM EDT
Filing Type: 10-Q
Importance Score:
8
EPC
May 06, 2026, 6:14 AM EDT
Filing Type: 8-K
Importance Score:
7
EPC
May 06, 2026, 6:00 AM EDT
Source: Reuters
Importance Score:
9
EPC
Feb 09, 2026, 1:35 PM EST
Filing Type: 10-Q
Importance Score:
8
EPC
Feb 09, 2026, 6:34 AM EST
Filing Type: 8-K
Importance Score:
7
EPC
Feb 06, 2026, 4:11 PM EST
Filing Type: 8-K
Importance Score:
8